SEC Form 4 · accession 0001209191-18-052048
Ampio Pharmaceuticals, Inc. · AMPE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
III Thomas E. Chilcott
Officer — Chief Financial Officer
Period of report
Sep 20, 2018
Accepted (ET)
Sep 24, 2018 · 5:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001411906
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $0.51 | Sep 20, 2018 | A | 75,000 | A | — | Sep 20, 2028 | Common Stock | 75,000 | 75,000 | D |
Explanation of responses
- F1The stock option has vested and has become fully exercisable.